PDA

View Full Version : FDA Grants IND For Pro-Pharmaceuticals' DAVANAT® To Treat Breast Cancer Patient


News
08-30-2008, 05:23 AM
Pro-Pharmaceuticals, Inc. (Amex: PRW), today announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of DAVANAT® in combination with 5-FU to treat a breast cancer patient at the Brown Cancer Center in Louisville, Kentucky. DAVANAT® also is being administered in Phase II clinical trials for first-line treatment of colorectal and biliary cancer patients.

More... (http://www.medicalnewstoday.com/articles/119792.php)

eric
08-30-2008, 07:47 AM
Another option, good news. Thanks for sharing. Eric